Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: li3511 who wrote (7925)	10/20/2009 7:41:32 PM
From: me otter	Read Replies (1) \| Respond to of 63324

From a chartist's perspective, we are likely to visit the $3.78 area before this down leg is done. We are oversold and should have a bounce from there. Looks to me like $5 is the magic number. A weekly close above there should signal that the selling pressure is about to become buying pressure.

To: li3511 who wrote (7925)	10/20/2009 9:42:19 PM
From: idahoranch1	Read Replies (1) \| Respond to of 63324

Li, there is ALWAYS something better in the future. The idea you mention may well be onto something. It sounds like a perfect DNL tri-fab mab match. But one of the "knocks" on Dr. Goldenberg has been he keeps wanting to improve his compounds and not take something through to approval and commercial use. This is where the rubber meets the road. If someone you love, or you, are diagnosed with stage lV PC tomorrow or next year, that new idea is WORTHLESS to you. hPAM4 might get you enough time that maybe it won't be. There is more than Calvin and Martha. It isn't a story that might unfold 4 years from now, it is already unfolding for some and some are benefiting. I'm curious to what you would do if you were diagnosed with stage lV PC tomorrow. I'd be trying to get into the hPAM4 trial. 3 to 6 months suddenly sounds pretty short.